Healthcare Infection Control Practices Advisory Committee (HICPAC), 28392 [2012-11547]

Download as PDF 28392 Federal Register / Vol. 77, No. 93 / Monday, May 14, 2012 / Notices Æ The solution will accept output from a wide range of ophthalmic devices and input formats, and convert to standard DICOM formats (e.g. using freeware tools). D Usability and interface for image viewing Æ The solution will have an easyto-use interface for clinicians with a range of experience and comfort level with technology. Æ The solution will provide the ability to view and annotate diagnosticquality ophthalmic images. D Integration with workflow Æ The solution will be convenient to integrate into clinical ophthalmology workflow, to install on existing office hardware platforms, and to integrate with existing EHR systems (e.g. ‘‘single sign-on’’). D Platform Neutrality Additional Information Ownership of intellectual property is determined by the following: D Each entrant retains title and full ownership in and to their submission. Entrants expressly reserve all intellectual property rights not expressly granted under the challenge agreement. D By participating in the challenge, each entrant hereby irrevocably grants to Sponsor and Administrator a limited, non-exclusive, royalty free, worldwide, license and right to reproduce, publically perform, publically display, and use the Submission to the extent necessary to administer the challenge, and to publically perform and publically display the Submission, including, without limitation, for advertising and promotional purposes relating to the challenge. Dated: May 7, 2012. Farzad Mostashari, National Coordinator for Health Information Technology. [FR Doc. 2012–11591 Filed 5–11–12; 8:45 am] emcdonald on DSK29S0YB1PROD with NOTICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Alcohol-related Motor Vehicle Injury Research, FOA CE12–006, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act Jkt 226001 [FR Doc. 2012–11546 Filed 5–11–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Healthcare Infection Control Practices Advisory Committee (HICPAC) DEPARTMENT OF HEALTH AND HUMAN SERVICES 14:46 May 11, 2012 Dated: May 8, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention BILLING CODE 4150–45–P VerDate Mar<15>2010 (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: TIME AND DATE: 12 p.m.–2:30 p.m., June 12, 2012 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. MATTERS TO BE DISCUSSED: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Alcohol-related Motor Vehicle Injury Research, FOA CE12–006, initial review.’’ CONTACT PERSON FOR MORE INFORMATION: Jane Suen, Dr.P.H., M.S., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341–3724, Telephone (770) 488–4281. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: TIMES AND DATES: 9:00 a.m.–5:00 p.m., June 14, 2012. 9:00 a.m.–12:00 p.m., June 15, 2012. PLACE: CDC, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia, 30333 PO 00000 Frm 00044 Fmt 4703 Sfmt 9990 Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/ hicpac. PURPOSE: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health and Human Services, the Director, CDC, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and the Director, Division of Healthcare Quality Promotion regarding 1) the practice of healthcare infection control; 2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and 3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections (HAIs) and healthcare-related conditions. MATTERS TO BE DISCUSSED: The agenda will include updates on CDC’s activities for HAIs including outbreaks and guidance on the use of single-dose vials; draft guideline for prevention of infections among patients in neonatal intensive care units (NICU); draft guideline for management of occupational exposures to HIV and recommendations for post-exposure prophylaxis; draft guidance for facility adjudication of infection data; and an update on National HealthCare Safety Network (NHSN) validation and surveillance definitions for central-line associated bloodstream infections and surgical site infections. Time will be available for public comment. Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., Mailstop A–07, Atlanta, Georgia, 30333, Telephone (404) 639–4045, Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. STATUS: Dated: May 3, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–11547 Filed 5–11–12; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 77, Number 93 (Monday, May 14, 2012)]
[Notices]
[Page 28392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11547]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

Times and Dates: 9:00 a.m.-5:00 p.m., June 14, 2012.
    9:00 a.m.-12:00 p.m., June 15, 2012.

Place:  CDC, Global Communications Center, Building 19, Auditorium B3, 
1600 Clifton Road NE., Atlanta, Georgia, 30333

Status:  Open to the public, limited only by the space available. 
Please register for the meeting at www.cdc.gov/hicpac.

Purpose: The Committee is charged with providing advice and guidance to 
the Secretary, the Assistant Secretary for Health and Human Services, 
the Director, CDC, the Director, National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), and the Director, Division of 
Healthcare Quality Promotion regarding 1) the practice of healthcare 
infection control; 2) strategies for surveillance, prevention, and 
control of infections (e.g., nosocomial infections), antimicrobial 
resistance, and related events in settings where healthcare is 
provided; and 3) periodic updating of guidelines and other policy 
statements regarding prevention of healthcare-associated infections 
(HAIs) and healthcare-related conditions.

Matters To Be Discussed:  The agenda will include updates on CDC's 
activities for HAIs including outbreaks and guidance on the use of 
single-dose vials; draft guideline for prevention of infections among 
patients in neonatal intensive care units (NICU); draft guideline for 
management of occupational exposures to HIV and recommendations for 
post-exposure prophylaxis; draft guidance for facility adjudication of 
infection data; and an update on National HealthCare Safety Network 
(NHSN) validation and surveillance definitions for central-line 
associated bloodstream infections and surgical site infections. Time 
will be available for public comment.
    Agenda items are subject to change as priorities dictate.

Contact Person for More Information:  Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton 
Road NE., Mailstop A-07, Atlanta, Georgia, 30333, Telephone (404) 639-
4045, Email: hicpac@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 3, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-11547 Filed 5-11-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.